September, 2020
SIGNAL study of pepinemab does not meet key goals for HD patients
Posted on September 24, 2020
The SIGNAL study was carried out by a company called Vaccinex to test whether their drug, pepinemab, could combat brain inflammation and ease symptoms…
Read MoreHighlights from the EHDN Virtual Congress
Posted on September 17, 2020
This week the 2020 European Huntington’s Disease Network (EHDN) hosted a virtual plenary meeting to discuss the latest in HD research…
Read MoreYou Asked the Scientists!
Posted on September 10, 2020
The recording from the latest HDSA Research Webinar, Ask the Scientist Anything, is now available on HDSA’s YouTube channel. Dr….
Read MoreResearch Webinar: Ask the Scientist…Anything!
Posted on September 3, 2020
This coming Tuesday, September 8th, at 12 PM Eastern, Dr. Ed Wild and Dr. Jeff Carroll, creators of HDBuzz, as well as HDBuzz writers Dr….
Read More